secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2026-07-20T21:55:01+00:00
Accession:  0000313616-26-000163
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher Q2 2026 EPS $1.23 (up 60% YoY), raises full-year adjusted EPS guidance to $8.45-$8.60
--------------------------------------------------------------------------------

- Net earnings $870M ($1.23 diluted EPS) up 60% YoY; adjusted EPS $1.94 up 8.0%.
- Revenue $6.3B (+5.5% YoY); core revenue +3.0% (+4.5% ex-respiratory testing).
- Operating cash flow $1.5B, free cash flow $1.3B.
- Full-year 2026 adjusted EPS guidance raised to $8.45-$8.60 from $8.35-$8.55.
- Bioprocessing orders grew mid-teens; Life Sciences had strongest quarter in years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361626000163/0000313616-26-000163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361626000163/dhr-20260721.htm
  HTML page:      https://secwatch.observer/filing/0000313616-26-000163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer